This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
source: pixabay.com

This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions

  A recent article in The American Journal of Managed Care (AJMC) heralds the approval of a third CAR T-cell therapy, called Tecartus. Kite Pharma’s cell-based gene therapy is the first…

Continue Reading This New Treatment for Mantle Cell Lymphoma has the Potential for Durable Remissions
Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy
source: pixabay.com

Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy

According to a story from the CureDuchenne Blog, Dr. Kevin Flanigan of Nationwide Children's Hospital has recently dosed two Duchenne muscular dystrophy patients with an experimental gene therapy. This gene…

Continue Reading Duchenne Muscular Dystrophy: Two Patients with a Rare Mutation Were Just Dosed with Gene Therapy
Tuberous Sclerosis Complex: CBD Oral Solution Epidiolex Approved to Treat Seizures
source: pixabay.com

Tuberous Sclerosis Complex: CBD Oral Solution Epidiolex Approved to Treat Seizures

According to a story from GlobeNewswire, the biopharmaceutical company GW Pharmaceuticals plc recently announced that its CBD oral solution Epidiolex® has recently been approved as a treatment for seizures associated…

Continue Reading Tuberous Sclerosis Complex: CBD Oral Solution Epidiolex Approved to Treat Seizures
Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia
source: pixabay.com

Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia

  Dr. Lindsay Wilde, an oncologist at the Hematologic Malignancies Division of Jefferson University, recently contributed to an article in the Oncology Times outlining her research team’s new study and…

Continue Reading Taking It One Step Further in the Quest to Prolong Survival in Acute Myeloid Leukemia
ICYMI: Recurrent Respiratory Papillomatosis Treatment Receives Orphan Drug Designation
source: pixabay.com

ICYMI: Recurrent Respiratory Papillomatosis Treatment Receives Orphan Drug Designation

INO-3107, a treatment for recurrent respiratory papillomatosis (RRP), has recently received the Orphan Drug Designation from the FDA. This treatment is currently being evaluate in a Phase 1/2 trial by…

Continue Reading ICYMI: Recurrent Respiratory Papillomatosis Treatment Receives Orphan Drug Designation
Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome
source: pixabay.com

Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome

  Researchers discovered surprising results after performing new studies of chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM). According to a report by Cort Johnson in HealthRising, the new studies give…

Continue Reading Studies from UCSF Offer New Perspective on Fibromyalgia and Chronic Fatigue Syndrome